α/β-Hydrolase domain-containing 6 (ABHD6) accelerates the desensitization and deactivation of TARP γ-2-containing AMPA receptors

This study demonstrates that the auxiliary subunit ABHD6 accelerates the desensitization and deactivation of TARP γ-2-containing AMPA receptors, thereby regulating their gating kinetics in a TARP γ-2-dependent manner.

The Gist

The Big Picture: The Brain's "Light Switch" and its "Dimmer"

Imagine your brain is a massive city of communication towers. The AMPA receptors are the light switches on these towers. When a signal (glutamate) arrives, the switch flips on, sending a burst of electricity to the next tower. This is how your brain thinks, learns, and remembers.

For the city to run smoothly, these lights need to flicker on and off at just the right speed.

• If they stay on too long, the city gets chaotic (like an epileptic seizure).
• If they turn off too fast, the message gets lost (like forgetting a phone number instantly).

Usually, there are "assistant proteins" (like TARP γ-2) that act as dimmer switches. They make the light stay on a little longer and glow brighter, ensuring the message gets through clearly.

The New Discovery: The "Speed-Bump" Protein (ABHD6)

This paper introduces a new character: a protein called ABHD6.

Think of ABHD6 as a traffic cop or a speed bump that shows up at the light switch.

• What it does: When ABHD6 is present, it doesn't just turn the light off; it makes the switch snap back to the "off" position super fast. It also makes the switch get "tired" (desensitized) quickly, so it stops responding to signals for a moment.
• The Catch: ABHD6 is a bit shy. It won't do this on its own. It only acts when the TARP γ-2 dimmer switch is already there. It's like a speed bump that only appears on a road that already has a traffic light.

The Experiments: Testing the Switches

The scientists wanted to see exactly how this traffic cop works. They built different types of "light switches" in a lab (using cells) to test every possible combination.

1. The Solo Switch: They tested the light switch alone. ABHD6 did nothing. (No traffic cop needed if there's no road).
2. The Dimmer Switch: They added the TARP γ-2 dimmer. The light stayed on longer (as expected).
3. The Traffic Cop Arrives: When they added ABHD6 alongside the dimmer, the light snapped off much faster than before.

The "Universal" Rule:
The scientists tried hundreds of different versions of these switches (some with different shapes, some with different "edits" to their code). They found that ABHD6 is a universal speed-bump: it works on almost every version of the switch, as long as the TARP γ-2 dimmer is present.

The One Exception:
There was one specific, rare version of the switch (GluA2(Q)i-G) where ABHD6 couldn't speed up the "off" switch. It's like a custom-made car that has a special suspension that ignores speed bumps.

The "Knockout" Test: What happens without the Cop?

To prove ABHD6 is important, the scientists looked at brain cells from mice that were born without ABHD6 (a "knockout").

• Without the Cop: The light switches stayed on too long. The signals were sluggish and slow to turn off.
• With the Cop (Normal Mice): The switches snapped back quickly, keeping the brain's communication crisp and fast.

Why Does This Matter?

Think of the brain as a high-speed internet connection.

• ABHD6 is the fiber-optic cable manager that ensures data packets don't get stuck.
• If you lose ABHD6, the data gets clogged, the connection slows down, and the system gets "noisy" (hyperexcitable).

The Takeaway:
This paper discovers that ABHD6 is a crucial regulator that works hand-in-hand with TARP γ-2 to make sure our brain's signals are fast, sharp, and short-lived. Without this "speed bump," our brain's communication becomes sluggish and potentially dangerous. This helps explain how our brain stays balanced and offers new clues for treating diseases like epilepsy or Alzheimer's, where this balance is broken.

Technical Summary

1. Problem Statement

AMPA receptors (AMPARs) are critical for fast excitatory synaptic transmission in the mammalian brain. Their functional efficacy is determined not only by their core subunit composition (GluA1-4) but also by their auxiliary subunits, which modulate gating kinetics (activation, deactivation, desensitization, and recovery).

• Known Context: ABHD6 is a known auxiliary subunit that negatively regulates the surface expression of AMPARs by trapping them in the endoplasmic reticulum (ER), thereby reducing current amplitude. It was previously observed that ABHD6 overexpression increased the decay time constant ($\tau$) of miniature excitatory postsynaptic currents (mEPSCs) in neurons.
• The Gap: It remained unclear whether ABHD6 directly regulates the gating kinetics (deactivation, desensitization, and recovery) of functional AMPARs at the cell surface, and if so, whether this regulation is dependent on specific auxiliary subunits (like TARP $\gamma$-2) or specific AMPAR isoforms (splice variants flip/flop and RNA editing Q/R or R/G).

2. Methodology

The study employed a combination of molecular biology, electrophysiology, and genetic knockout approaches:

• Cell Models: HEK 293T cells were used for heterologous expression to systematically test various receptor combinations. Primary hippocampal neurons from ABHD6-knockout (KO) mice were used to validate findings in a physiological context.
• Receptor Variants: The authors constructed 14 distinct AMPAR variants covering:
  • Subunits: GluA1, GluA2, GluA3, and GluA4.
  • Splice Variants: Flip (i) and Flop (o).
  • RNA Editing: GluA2 Q/R editing (Q or R at position 607) and R/G editing (R or G at position 764).
  • Combinations: Homomeric receptors and heteromeric complexes (GluA1/GluA2 and GluA2/GluA3).
• Experimental Conditions:
  • Co-expression of AMPARs with ABHD6, TARP $\gamma$-2, or both.
  • Use of chimeric plasmids (fusing GluA and TARP $\gamma$-2) to ensure a 1:1 stoichiometry and rule out changes in the ratio of TARPed vs. unTARPed receptors.
  • Spermine isolation: Recording at +50 mV with spermine in the internal solution to isolate TARP-containing receptors from unTARPed ones.
• Electrophysiology:
  • Outside-out patch-clamp recordings with ultra-fast glutamate application (1 ms for deactivation, 100 ms for desensitization).
  • Paired-pulse stimulation (100 ms pulses with varying intervals) to measure recovery from desensitization.
  • Analysis of weighted time constants ($\tau_w$) for deactivation, desensitization, and recovery.
• Validation: Immunofluorescence, Western blotting, and affinity chromatography were used to confirm co-expression and protein interactions.

3. Key Contributions

This study provides the first comprehensive characterization of ABHD6's role in modulating AMPAR gating kinetics rather than just trafficking. The key contributions include:

1. Discovery of a Kinetic Mechanism: Establishing that ABHD6 accelerates the deactivation and desensitization of AMPARs, but only in the presence of the auxiliary subunit TARP $\gamma$-2.
2. Isoform Independence: Demonstrating that this kinetic regulation is largely independent of AMPAR subunit type, flip/flop splice variants, and RNA editing (Q/R or R/G), with a specific exception for the deactivation of the GluA2(Q)i-G isoform.
3. Heteromeric Receptor Regulation: Showing that ABHD6 accelerates kinetics in native-like heteromeric complexes (GluA1/GluA2 and GluA2/GluA3) when TARP $\gamma$-2 is present.
4. Physiological Validation: Confirming that ABHD6 knockout neurons exhibit significantly slower deactivation and desensitization, proving the physiological relevance of this regulatory pathway.

4. Detailed Results

A. Current Amplitude

• ABHD6 overexpression consistently reduced the peak amplitude of glutamate-induced currents across all tested AMPAR variants (both homomeric and heteromeric), regardless of the presence of TARP $\gamma$-2. This confirms its role in reducing surface expression.

B. Deactivation Kinetics ($\tau_{w, deact}$)

• Without TARP $\gamma$-2: ABHD6 had no significant effect on the deactivation kinetics of homomeric AMPARs.
• With TARP $\gamma$-2: ABHD6 significantly accelerated (reduced the time constant of) deactivation for GluA1 and GluA2(Q) homomers, as well as GluA1/GluA2 and GluA2/GluA3 heteromers.
  • Exception: The deactivation of the GluA2(Q)i-G isoform was not significantly accelerated by ABHD6.
• Mechanism Check: Using chimeric plasmids and spermine isolation techniques, the authors confirmed that the acceleration occurred specifically on the TARP $\gamma$-2-containing receptors, ruling out artifacts caused by changing the ratio of TARPed to unTARPed receptors.

C. Desensitization Kinetics ($\tau_{w, des}$)

• Similar to deactivation, ABHD6 had no effect on desensitization in the absence of TARP $\gamma$-2.
• In the presence of TARP $\gamma$-2, ABHD6 significantly accelerated desensitization (reduced $\tau_{w, des}$) for all tested isoforms (GluA1, GluA2(Q), and heteromers).

D. Recovery from Desensitization ($\tau_{rec}$)

• General Effect: ABHD6 had minimal effect on recovery kinetics for most combinations.
• Specific Effect: ABHD6 significantly slowed the recovery from desensitization (increased $\tau_{rec}$) specifically for GluA1i-TARP $\gamma$-2 complexes. This suggests a specific regulatory interaction for the GluA1 flip isoform.

E. Neuronal Validation (ABHD6 KO)

• In primary hippocampal neurons from ABHD6-knockout mice:
  • Deactivation and desensitization kinetics were slower (increased $\tau$) compared to wild-type neurons.
  • Peak current amplitudes were higher.
  • This confirms that endogenous ABHD6 acts as a "brake" on synaptic transmission speed and amplitude in a TARP-dependent manner.

F. Extension to Other TARPs

• The study also found that ABHD6 accelerates deactivation and desensitization in GluA4-TARP $\gamma$-2 complexes and GluA1-TARP $\gamma$-8 complexes, suggesting this regulatory mechanism may extend to other TARP family members.

5. Significance

• Novel Regulatory Logic: The findings reveal a combinatorial regulatory logic where ABHD6 does not act as a standalone modulator of AMPAR kinetics but functions as a TARP $\gamma$-2-dependent accelerator. This contrasts with the canonical role of TARPs (like $\gamma$-2), which typically slow deactivation and desensitization. ABHD6 effectively counteracts the slowing effect of TARP $\gamma$-2, fine-tuning the receptor's temporal response.
• Synaptic Integration: By accelerating deactivation and desensitization while reducing current amplitude, ABHD6 narrows the temporal window for synaptic integration and reduces total charge transfer. This acts as a "molecular brake" on excitatory synaptic transmission.
• Pathological Implications: Dysregulation of ABHD6 could lead to altered synaptic plasticity and neuronal excitability.
  • Loss of ABHD6: Could lead to hyperexcitability (prolonged currents), potentially contributing to epilepsy.
  • Excessive ABHD6: Could lead to synaptic dysfunction and impaired plasticity, potentially linked to cognitive disorders like Alzheimer's disease.
• Therapeutic Target: ABHD6 emerges as a promising target for neurological disorders involving excitotoxicity or synaptic plasticity deficits, offering a mechanism to modulate synaptic strength and kinetics distinct from traditional receptor antagonists.

In summary, this paper redefines ABHD6 not just as a trafficking inhibitor, but as a critical kinetic modulator that dynamically shapes AMPAR function in a TARP $\gamma$-2-dependent manner, providing a new layer of complexity to our understanding of synaptic transmission regulation.